Traumatic Brain Injury(TBI) - Pipeline Insights, 2017

Publisher Name :
Date: 01-Nov-2017
No. of pages: 156
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Traumatic Brain Injury-Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this indication. Key objective of the report is to establish the understanding for all the pipeline drugs that fall under Traumatic Brain Injury. This report provides information on the therapeutic development based on the Traumatic Brain Injury dealing with all the pipeline drugs, comparative analysis of Traumatic Brain Injury at various stages covering Phase III, Phase II, Phase I, IND, Pre-clinical, and Discovery stages therapeutics assessment by monotherapy products and molecule type drug information. The report also covers the company's information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight's team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Traumatic Brain Injury(TBI) - Pipeline Insights, 2017

Table of Contents

Introduction
Overview
Pipeline Therapeutics
Therapeutics under Development by Companies
Late Stage Products (Phase III)
Mid Stage Products (Phase II)
Early Stage Products (Phase I and IND)
Pre-clinical and Discovery Products
Therapeutic Assessment: Active Products
Dormant Products
Discontinued Products
Comparative Analysis
Companies involved in Therapeutic Development
Appendix
Consulting Services
About DelveInsight
Contact Us
Disclaimer

List of Tables

Table 1: Number of Products Under Development for Traumatic Brain Injury
Table 2: Number of Products under Development by Companies
Table 3: Late Stage Products (Phase III)
Table 4: Mid Stage Products (Phase II)
Table 5: Early Stage Products (Phase I and IND)
Table 6: Pre-clinical Products
Table 7: Discovery Products
Table 8: Assessment by Monotherapy Products
Table 9: Assessment by Combination Therapy Products
Table 10: Assessment by Route Of Administration
Table 11:Assessment by Stage and Route Of Administration
Table 12: Assessment by Molecule Type
Table 13: Assessment by Stage and Molecule Type
Table 14: Dormant Products
Table 15: Discontinued Products
Table 16: American Life Science Pharmaceuticals (ALSP), Overview
Table 17: Anvyl LLC, Overview
Table 18: Apollo Endosurgery, Overview
Table 19: Aptinyx, Overview
Table 20: Astrocyte Pharmaceuticals Inc., Overview
Table 21: Athersys, Overview
Table Continued…
Table 56: VG Life Sciences, Overview

List of Figures

Figure 1: Symptoms of Traumatic Brain Injury
Figure 2:Number of Products under Development for Traumatic Brain Injury,2017
Figure 3: Late Stage Products (Phase III)
Figure 4: Mid Stage Products (Phase II)
Figure 5: Early Stage Products (Phase I and IND)
Figure 6: Pre-clinical and Discovery Products
Figure 7: Assessment by Monotherapy Products
Figure 8: Assessment by Combination Therapy Products
Figure 9: Assessment by Route of Administration
Figure 10: Assessment by Stage and Route of Administration
Figure 11: Assessment by Molecule Type
Figure 12: Assessment by Stage and Molecule Type
Figure 13: Dormant Products
Figure 14: Discontinued Products
  • Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 39
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple System Atrophy - Pipeline Review, H2 2017, provides an overview of the Multiple System Atrophy (Central Nervous System) pipeline landscape. Multiple system atrophy (MSA) or Shy-Drager syndrome is a neurological disorder that impairs body's involuntary functions (blood pressure, heart rate, bladder function and digestion). Symptoms include rigid muscles, bradykinesia, Tremors, dysarthria, d......
  • Progressive Supranuclear Palsy - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 80
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclear Palsy - Pipeline Review, H2 2017, provides an overview of the Progressive Supranuclear Palsy (Central Nervous System) pipeline landscape. Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing. Symptoms include fatigue, headaches, dizz......
  • Neuropathic Pain - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 488
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H2 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many......
  • Smoking Addiction - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 89
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smoking Addiction - Pipeline Review, H2 2017, provides an overview of the Smoking Addiction (Central Nervous System) pipeline landscape. Smoking is addictive, people experience an uncontrollable dependence on cigarettes, which on stopping will cause severe mental, emotional or physical reactions. People addicted to smoking develop tolerance to nicotine. Nicotine acts on acetylcholine receptors caus......
  • Global and United States Alcohol Addiction Therapeutics In-Depth Research Report 2017-2022
    Published: 26-Dec-2017        Price: US 3190 Onwards        Pages: 110
    The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Alcohol Addiction Therapeutics industry. Major Companies - AstraZeneca Plc - BioCorRx Inc......
  • Global Alcohol Addiction Therapeutics Sales Market Report 2018
    Published: 25-Dec-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the global Alcohol Addiction Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Alcohol Addiction Therapeutics for these regions, from 2012 to 2022 (forecast), covering - United States - China ......
  • 2015-2023 World Gabapentin Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 19-Dec-2017        Price: US 2800 Onwards        Pages: 136
    Summary Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. M......
  • Encephalopathy - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2000 Onwards        Pages: 58
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Pipeline Review, H2 2017, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape. Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, involuntary twitching and muscle weakness. Causes include traumas......
  • Canavan Disease - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2000 Onwards        Pages: 27
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Pipeline Review, H2 2017, provides an overview of the Canavan Disease (Central Nervous System) pipeline landscape. Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutation in the gene which directs the production of the enzyme asparto......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs